Subcommittee on Procedures Review, Advisory Board on Radiation and Worker Health (ABRWH), National Institute for Occupational Safety and Health (NIOSH), 11483-11484 [2011-4597]
Download as PDF
<![CDATA[
emcdonald on DSK2BSOYB1PROD with NOTICES
Federal Register / Vol. 76, No. 41 / Wednesday, March 2, 2011 / Notices
and technological innovation. In
undertaking these duties, the
Commission seeks to identify and
examine specific bioethical, legal, and
social issues related to potential
scientific and technological advances;
examine diverse perspectives and
possibilities for international
collaboration on these issues; and
recommend legal, regulatory, or policy
actions as appropriate.
The Commission has begun a review
of the current rules and standards for
protecting human subjects in scientific
studies supported by the Federal
Government. The President requested
this study on November 24, 2010,
following revelations that the U.S.
Public Health Service supported
research on sexually transmitted
diseases in Guatemala from 1946 to
1948 involving the intentional infection
of vulnerable populations. President
Obama asked the Commission Chair ‘‘to
convene a panel to conduct * * * a
thorough review of human subjects
protection to determine if Federal
regulations and international standards
adequately guard the health and wellbeing of participants in scientific
studies supported by the Federal
Government.’’
The President charged the
Commission to seek the insights and
perspective of international experts and
consult with counterparts in the global
community. The Commission will
provide the President with a report of its
findings and recommendations later this
year.
To implement this mission, the
Commission wishes to develop a
thorough understanding of the current
U.S. and international standards for
protecting the health and well-being of
participants in scientific studies
supported by the Federal Government.
To this end, the Commission is inviting
interested parties to provide input and
advice through written comments.
Among other issues, the Commission is
interested in receiving comments on the
existing standards for protecting human
subjects, both domestically and
internationally; how the current system
of global research works in practice; and
the ethical and social justice issues that
emerge from the current research
system. Comments concerning the
benefits of medical research; differences
across global norms and standards;
standards for ancillary care and posttrial access to treatment; trial design;
duties to participants; challenges, if any,
faced by U.S.-funded researchers
working internationally, or international
researchers collaborating on U.S.funded research; and other specific
information are all especially welcome.
VerDate Mar<15>2010
16:34 Mar 01, 2011
Jkt 223001
11483
reconstruction efforts being performed
for purposes of the compensation
program; and advice on petitions to add
classes of workers to the Special
Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the ABRWH to
HHS, which subsequently delegated this
authority to CDC. NIOSH implements
this responsibility for CDC. The charter
was issued on August 3, 2001, renewed
at appropriate intervals, and will expire
on August 3, 2011.
Purpose: The ABRWH is charged with
Dated: February 17, 2011.
(a) Providing advice to the Secretary,
Valerie H. Bonham,
HHS, on the development of guidelines
Executive Director, The Presidential
under Executive Order 13179; (b)
Commission for the Study of Bioethical Issues. providing advice to the Secretary, HHS,
[FR Doc. 2011–4658 Filed 3–1–11; 8:45 am]
on the scientific validity and quality of
BILLING CODE 4154–06–P
dose reconstruction efforts performed
for this program; and (c) upon request
by the Secretary, HHS, advising the
DEPARTMENT OF HEALTH AND
Secretary on whether there is a class of
HUMAN SERVICES
employees at any Department of Energy
facility who were exposed to radiation
Centers for Disease Control and
but for whom it is not feasible to
Prevention
estimate their radiation dose, and on
whether there is a reasonable likelihood
Subcommittee on Procedures Review,
that such radiation doses may have
Advisory Board on Radiation and
endangered the health of members of
Worker Health (ABRWH), National
this class. The Subcommittee on
Institute for Occupational Safety and
Procedures Review was established to
Health (NIOSH)
aid the ABRWH in carrying out its duty
In accordance with section 10(a)(2) of to advise the Secretary, HHS, on dose
the Federal Advisory Committee Act
reconstructions. The Subcommittee on
(Pub. L. 92–463), the Centers for Disease Procedures Review is responsible for
Control and Prevention (CDC)
overseeing, tracking, and participating
announces the following meeting for the in the reviews of all procedures used in
the dose reconstruction process by the
aforementioned subcommittee:
Time and Date: 9 a.m.–5 p.m., March
NIOSH Division of Compensation
22, 2011.
Analysis and Support (DCAS) and its
Place: Cincinnati Airport Marriott,
dose reconstruction contractor.
2395 Progress Drive, Hebron, KY 41018.
Matters to be Discussed: The agenda
Telephone (859) 334–4611, Fax (859)
for the Subcommittee meeting includes
discussion of the following ORAU and
334–4619.
Status: Open to the public, but
OCAS procedures: ORAUT–RPRT–0044
without a public comment period. To
(‘‘Analysis of Bioassay Data with a
access by conference call dial the
Significant Fraction of Less-Than
following information: (866) 659–0537,
Results’’), OCAS TIB–0013 (‘‘Special
Participant Pass Code 9933701.
External Dose Reconstruction
Background: The ABRWH was
Considerations for Mallinckrodt
established under the Energy Employees Workers’’), OTIB–014 (‘‘Rocky Flats
Occupational Illness Compensation
Internal Dosimetry Co-Worker
Program Act of 2000 to advise the
Extension’’), OTIB–019 (‘‘Analysis of
President on a variety of policy and
Coworker Bioassay Data for Internal
technical functions required to
Dose Assignment’’), OTIB–0029
implement and effectively manage the
(‘‘Internal Dosimetry Coworker Data for
compensation program. Key functions of Y–12’’), OTIB–0047 (‘‘External Radiation
Monitoring at the Y–12 Facility During
the ABRWH include providing advice
the 1948–1949 Period’’), OTIB–0049
on the development of probability of
(‘‘Estimating Doses for Plutonium
causation guidelines that have been
Strongly Retained in the Lung’’), OTIB–
promulgated by the Department of
0052 (‘‘Parameters to Consider When
Health and Human Services (HHS) as a
Processing Claims for Construction
final rule; advice on methods of dose
Trade Workers’’), OTIB–0054 (‘‘Fission
reconstruction which have also been
and Activation Product Assignment for
promulgated by HHS as a final rule;
Internal Dose-Related Gross Beta and
advice on the scientific validity and
Gross Gamma Analyses’’), and OTIB–
quality of dose estimation and
The Commission is under a very tight
deadline and would appreciate
comments within 60 days.
Please address comments by e-mail to
info@bioethics.gov, or by mail to the
following address: Public Commentary,
The Presidential Commission for the
Study of Bioethical Issues, 1425 New
York Ave. NW., Suite C–100,
Washington, DC 20005. Comments will
be publicly available, including any
personally identifiable or confidential
business information that they contain.
Trade secrets should not be submitted.
PO 00000
Frm 00060
Fmt 4703
Sfmt 4703
E:\FR\FM\02MRN1.SGM
02MRN1
11484
Federal Register / Vol. 76, No. 41 / Wednesday, March 2, 2011 / Notices
0070 (‘‘Dose Reconstruction During
Residual Radioactivity Periods at
Atomic Weapons Employer Facilities’’);
and a continuation of the commentresolution process for other dose
reconstruction procedures under review
by the Subcommittee.
The agenda is subject to change as
priorities dictate.
This meeting is open to the public,
but without a public comment period.
In the event an individual wishes to
provide comments, written comments
may be submitted. Any written
comments received will be provided at
the meeting and should be submitted to
the contact person below in advance of
the meeting.
Contact Person for More Information:
Theodore Katz, Executive Secretary,
NIOSH, CDC, 1600 Clifton Road,
Mailstop E–20, Atlanta, GA 30333,
Telephone (513) 533–6800, Toll Free 1
(800) CDC–INFO, E-mail dcas@cdc.gov.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention, and the Agency for Toxic
Substances and Disease Registry.
Dated: February 24, 2011.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2011–4597 Filed 3–1–11; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–9978–N2]
Public Meeting of the Consumer
Operated and Oriented Plan (CO–OP)
Advisory Board, March 14, 2011
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice of meeting.
AGENCY:
This notice announces the
third meeting of an advisory committee
to the Center for Consumer Information
and Insurance Oversight (CCIIO) in
accordance with the Federal Advisory
Committee Act. The meeting is open to
the public. The purpose of the meeting
is to assist and advise the Secretary and
the Congress on the Department’s
strategy to foster the creation of
qualified nonprofit health insurance
issuers. Specifically, the Committee
emcdonald on DSK2BSOYB1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
16:34 Mar 01, 2011
Jkt 223001
shall advise the Secretary and the
Congress concerning the award of grants
and loans related to Section 1322 of the
Affordable Care Act, which provides for
a Federal program to assist
establishment and operation of
nonprofit, member run health insurance
issuers. In these matters, the Committee
shall consult with all components of the
Department, other federal entities, and
non-Federal organizations, as
appropriate; and examine relevant data
sources to assess the grant and loan
award strategy to provide
recommendations to CCIIO.
DATES: Meeting Date: March 14, 2011
from 8:30 a.m. to 5 p.m., Eastern
Standard Time (EST) Deadline for
Meeting Registration, Presentations and
Comments: March 10, 2011, 5 p.m.,
EST. Deadline for Requesting Special
Accommodations: March 10, 2011, 5
p.m., EST.
ADDRESSES: Meeting Location: Madison
Hotel, 1177 15th Street, NW.,
Washington, DC 20005.
Meeting Online Access: To participate
in this meeting via the Internet, go to
https://www.readyshow.com/ and enter
participant code 49888151. Note that
audio of the meeting will only be
broadcast through the conference phone
line.
Meeting Phone Access: To participate
in this meeting via phone, please dial
into the toll free phone number 1–888–
299–4099, and provide the following
code to the operator: VW38426.
Meeting Registration, Presentations,
and Written Comments: Anne Bollinger,
Center for Consumer Information and
Insurance Oversight, CMS, 200
Independence Avenue, SW.,
Washington, DC 20201, 301–492–395,
Fax: 301–492–4462, or contact by e-mail
at anne.bollinger@hhs.gov. Written
comments must be submitted in Word
format.
Registration: The meeting is open to
the public, but attendance is limited to
the space available. Persons wishing to
attend this meeting must register by
contacting the designated Federal
official at the address listed in the
ADDRESSES section of this notice or by
telephone at the number listed in the
FOR FURTHER INFORMATION CONTACT
section of this notice, by the date listed
in the DATES section of this notice.
FOR FURTHER INFORMATION CONTACT:
Anne Bollinger, 301–492–4395. Press
inquiries are handled through CCIIO’s
Press Office at (202) 690–6343.
SUPPLEMENTARY INFORMATION:
I. Background
The purpose of the meeting is to assist
and advise the Secretary and the
PO 00000
Frm 00061
Fmt 4703
Sfmt 4703
Congress on the Department’s strategy to
foster the creation of qualified nonprofit
health insurance issuers. Specifically,
the Committee shall advise the
Secretary and the Congress concerning
the award of grants and loans related to
section 1322 of the Affordable Care Act,
which provides for a Federal program to
assist establishment and operation of
nonprofit, member run health insurance
issuers. In these matters, the Committee
shall consult with all components of the
Department, other Federal entities, and
non-Federal organizations, as
appropriate; and examine relevant data
sources to assess the grant and loan
award strategy to provide
recommendations to CCIIO.
II. Meeting Agenda
The Committee will hear comments
from the public and then begin
deliberations on proposed
recommendations presented by the
work groups from the Committee. CCIIO
intends to make background material
available to the public no later than two
(2) business days prior to the meeting.
If CCIIO is unable to post the
background material on its Web site
prior to the meeting, it will be made
publicly available at the location of the
advisory committee meeting, and the
background material will be posted on
CCIIO’s Web site after the meeting, at
https://hhs.gov/CCIIO.
Oral comments from the public will
be scheduled between approximately
8:30 a.m.–9:30 a.m. Individuals or
organizations that wish to make a 3minute oral presentation on an agenda
topic should submit a written copy in
Word format of the oral presentation to
the designated federal official (DFO) at
the address listed in the ADDRESSES
section of this notice by the date listed
in the DATES section of this notice. The
number of oral presentations may be
limited by the time available. Persons
attending CCIIO’s advisory committee
meetings are advised that the agency is
not responsible for providing access to
electrical outlets. If the number of
speakers requesting to comment is
greater than can be reasonably
accommodated during the scheduled
open public comment session, CCIIO
will take written comments after the
meeting until close of business.
Individuals not wishing to make a
presentation may submit written
comments in Word format to the DFO at
the address listed in the ADDRESSES
section of this notice by the date listed
in the DATES section of this notice.
Individuals requiring sign language
interpretation or other special
accommodations must contact the DFO
via the contact information specified in
E:\FR\FM\02MRN1.SGM
02MRN1
]]>Agencies
[Federal Register Volume 76, Number 41 (Wednesday, March 2, 2011)]
[Notices]
[Pages 11483-11484]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-4597]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Subcommittee on Procedures Review, Advisory Board on Radiation
and Worker Health (ABRWH), National Institute for Occupational Safety
and Health (NIOSH)
In accordance with section 10(a)(2) of the Federal Advisory
Committee Act (Pub. L. 92-463), the Centers for Disease Control and
Prevention (CDC) announces the following meeting for the aforementioned
subcommittee:
Time and Date: 9 a.m.-5 p.m., March 22, 2011.
Place: Cincinnati Airport Marriott, 2395 Progress Drive, Hebron, KY
41018. Telephone (859) 334-4611, Fax (859) 334-4619.
Status: Open to the public, but without a public comment period. To
access by conference call dial the following information: (866) 659-
0537, Participant Pass Code 9933701.
Background: The ABRWH was established under the Energy Employees
Occupational Illness Compensation Program Act of 2000 to advise the
President on a variety of policy and technical functions required to
implement and effectively manage the compensation program. Key
functions of the ABRWH include providing advice on the development of
probability of causation guidelines that have been promulgated by the
Department of Health and Human Services (HHS) as a final rule; advice
on methods of dose reconstruction which have also been promulgated by
HHS as a final rule; advice on the scientific validity and quality of
dose estimation and reconstruction efforts being performed for purposes
of the compensation program; and advice on petitions to add classes of
workers to the Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the ABRWH to HHS, which subsequently
delegated this authority to CDC. NIOSH implements this responsibility
for CDC. The charter was issued on August 3, 2001, renewed at
appropriate intervals, and will expire on August 3, 2011.
Purpose: The ABRWH is charged with (a) Providing advice to the
Secretary, HHS, on the development of guidelines under Executive Order
13179; (b) providing advice to the Secretary, HHS, on the scientific
validity and quality of dose reconstruction efforts performed for this
program; and (c) upon request by the Secretary, HHS, advising the
Secretary on whether there is a class of employees at any Department of
Energy facility who were exposed to radiation but for whom it is not
feasible to estimate their radiation dose, and on whether there is a
reasonable likelihood that such radiation doses may have endangered the
health of members of this class. The Subcommittee on Procedures Review
was established to aid the ABRWH in carrying out its duty to advise the
Secretary, HHS, on dose reconstructions. The Subcommittee on Procedures
Review is responsible for overseeing, tracking, and participating in
the reviews of all procedures used in the dose reconstruction process
by the NIOSH Division of Compensation Analysis and Support (DCAS) and
its dose reconstruction contractor.
Matters to be Discussed: The agenda for the Subcommittee meeting
includes discussion of the following ORAU and OCAS procedures: ORAUT-
RPRT-0044 (``Analysis of Bioassay Data with a Significant Fraction of
Less-Than Results''), OCAS TIB-0013 (``Special External Dose
Reconstruction Considerations for Mallinckrodt Workers''), OTIB-014
(``Rocky Flats Internal Dosimetry Co-Worker Extension''), OTIB-019
(``Analysis of Coworker Bioassay Data for Internal Dose Assignment''),
OTIB-0029 (``Internal Dosimetry Coworker Data for Y-12''), OTIB-0047
(``External Radiation Monitoring at the Y-12 Facility During the 1948-
1949 Period''), OTIB-0049 (``Estimating Doses for Plutonium Strongly
Retained in the Lung''), OTIB-0052 (``Parameters to Consider When
Processing Claims for Construction Trade Workers''), OTIB-0054
(``Fission and Activation Product Assignment for Internal Dose-Related
Gross Beta and Gross Gamma Analyses''), and OTIB-
[[Page 11484]]
0070 (``Dose Reconstruction During Residual Radioactivity Periods at
Atomic Weapons Employer Facilities''); and a continuation of the
comment-resolution process for other dose reconstruction procedures
under review by the Subcommittee.
The agenda is subject to change as priorities dictate.
This meeting is open to the public, but without a public comment
period. In the event an individual wishes to provide comments, written
comments may be submitted. Any written comments received will be
provided at the meeting and should be submitted to the contact person
below in advance of the meeting.
Contact Person for More Information: Theodore Katz, Executive
Secretary, NIOSH, CDC, 1600 Clifton Road, Mailstop E-20, Atlanta, GA
30333, Telephone (513) 533-6800, Toll Free 1 (800) CDC-INFO, E-mail
dcas@cdc.gov.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention, and the Agency
for Toxic Substances and Disease Registry.
Dated: February 24, 2011.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2011-4597 Filed 3-1-11; 8:45 am]
BILLING CODE 4163-18-P
